LGALS9 and carcinoma: HPV-positive CC tumors exhibited epithelial cells with significant enrichment of immune checkpoint ligands (LGALS9, CD274, and TNFRSF14), whereas HPV-negative carcinomas predominantly activated the CD80/86-CTLA4 pathway.